 | Up a level |
Maertens, Johan A., Raad, Issam I., Marr, Kieren A., Patterson, Thomas F., Kontoyiannis, Dimitrios P., Cornely, Oliver A., Bow, Eric J., Rahav, Galia, Neofytos, Dionysios 
ORCID: 0000-0001-6970-2869, Aoun, Mickael, Baddley, John W., Giladi, Michael, Heinz, Werner J., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Hope, William ORCID: 0000-0001-6187-878X, Karthaus, Meinolf, Lee, Dong-Gun ORCID: 0000-0003-4655-0641, Lortholary, Olivier, Morrison, Vicki A., Oren, Ilana, Selleslag, Dominik, Shoham, Shmuel, Thompson, George R., III, Lee, Misun, Maher, Rochelle M., Schmitt-Hoffmann, Anne-Hortense, Zeiher, Bernhardt and Ullmann, Andrew J.
(2016).
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet, 387 (10020).
S. 760 - 770.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Marr, Kieren A., Schlamm, Haran T., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Rottinghaus, Scott T., Bow, Eric J., Cornely, Oliver A., Heinz, Werner J., Jagannatha, Shyla, Koh, Liang Piu, Kontoyiannis, Dimitrios P., Lee, Dong-Gun ORCID: 0000-0003-4655-0641, Nucci, Marcio, Pappas, Peter G., Slavin, Monica A., Queiroz-Telles, Flavio, Selleslag, Dominik, Walsh, Thomas J., Wingard, John R. and Maertens, Johan A.
(2015).
Combination Antifungal Therapy for Invasive Aspergillosis A Randomized Trial.
Ann. Intern. Med., 162 (2).
S. 81 - 90.
PHILADELPHIA:
AMER COLL PHYSICIANS.
ISSN 1539-3704